Profil
Leah Makley was the founder of Viewpoint Therapeutics, Inc., founded in 2014, and held the title of Chief Executive Officer.
Dr. Makley currently holds the positions of Chief Operations Officer at MBC Biolabs and Chief Operating Officer at Deciduous Therapeutics, Inc. since 2022.
Dr. Makley completed an undergraduate degree at the University of Dayton in 2009 and a doctorate at the University of Michigan in 2014.
Postes actifs de Leah Makley
| Sociétés | Poste | Début |
|---|---|---|
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Directeur des opérations | 01/02/2022 |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Directeur des opérations | - |
Anciens postes connus de Leah Makley
| Sociétés | Poste | Fin |
|---|---|---|
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Directeur Général | 01/02/2022 |
Formation de Leah Makley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Commercial Services |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
















